Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal X-ray, COVID-19
Clinical narrative: she got her shots but still got covid; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (she got her shots but still got covid) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 047B21A) for COVID-19 prophylaxis.     Previously administered products included for Smoking cessation therapy: Chantix (Film-coated tablet, dose was 0.5 or 1 mg, Outcome was recovering.) from November 2020 to February 2021, Chantix (Film-coated tablet, dose was 0.5 or 1 mg, Outcome was recovering.) from November 2020 to February 2021, Chantix (Film-coated tablet, dose was 0.5 or 1 mg, Outcome was recovering.) from November 2020 to February 2021, Chantix (Film-coated tablet, dose was 0.5 or 1 mg, Outcome was recovering.) from November 2020 to February 2021, Chantix (Film-coated tablet, dose was 0.5 or 1 mg and Outcome was recovering.) from November 2020 to February 2021. Past adverse reactions to the above products included Abdominal discomfort with Chantix; Constipation with Chantix; Dry heaves with Chantix; Dry mouth with Chantix; and Feeling miserable with Chantix.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (she got her shots but still got covid). At the time of the report, COVID-19 (she got her shots but still got covid) outcome was unknown. Unknown    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Aug-2021, Abdominal X-ray: constipation constipation.         Patient stopped taking Chantix due to Constipation which was working right. The patient felt better 3 days after quitting Chantix. The starter pack of Chantix expired Nov-2020. The patient's mouth was so dry, This started about the last month that she took Chantix.  The patient took her last dose of Chantix on 10-Feb-2021 or 11-Feb-2021.  No concomitant product reported by reporter. No treatment medication reported by reporter.  Company comment: This spontaneous case concerns a 62-year-old female patient, with no reported medical history, who experienced the unexpected non-serious AESI COVID-19 after receiving the 2nd dose of mRNA-1273 vaccine. The onset date of the event was not reported. Clinical course and treatment details were not reported. Patient received the first dose of mRNA-1273 vaccine 28 days prior to current mRNA-1273 vaccine. The outcome of event was unknown. The benefit-risk relationship of mRNA-1273 is not affected by this report. Event was assessed as non-serious based on medical judgement.; Sender's Comments: This spontaneous case concerns a 62-year-old female patient, with no reported medical history, who experienced the unexpected non-serious AESI COVID-19 after receiving the 2nd dose of mRNA-1273 vaccine. The onset date of the event was not reported. Clinical course and treatment details were not reported. Patient received the first dose of mRNA-1273 vaccine 28 days prior to current mRNA-1273 vaccine. The outcome of event was unknown. The benefit-risk relationship of mRNA-1273 is not affected by this report. Event was assessed as non-serious based on medical judgement.